Metabolism of 2,6-dinitro[3-³H]toluene by human and rat liver microsomal and cytosolic fractions

References

• Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Brodfuehrer J. I., Chapman D. E., Wilke T. J., Powis G. Comparative studies of the in vitro metabolism and covalent binding of [14C] benzene by liver slices and microsomal fraction of mouse, rat and human. Drug Metabolism and Disposition 1989; 18: 20–27
   Google Scholar
• Chapman D. E., Moore T. J., Michener S. R., Powis G. In vitro metabolism of [14C]-toluene by human and rat liver microsomal fractions and liver slices. Drug Metabolism and Disposition 1990; 18: 929–936
   PubMed Web of Science ®Google Scholar
• CIIt, Chemical Industry Institute of Toxicology. 104-week chronic toxicity study in rats. Hazleton Laboratories America, Inc., Vienna, VA 1982, Dinitrotoluene. Project No. 2010–101
   Google Scholar
• Dent J. G., Schnell S., Guest D. Metabolism of 2,4-dinitrotoluene in rat hepatic microsomes and cecal flora. Biological and Reactive Intermediates II: Chemical Mechanisms and Biological Effects, R. Snyder, D. V. Parke, J. J. Kocsis, D. J. Jollow, G. G. Gibson, C. M. Widner. Plenum, New York 1981; 431–436
   Google Scholar
• Dixit R., Schut H. A. J., Klaunig J. E., Stoner G. D. Metabolism and DNA binding of 2,6-dinitrotoluene in Fischer-344 rats and A/J mice. Toxicology and Applied Pharmacology 1986; 82: 53–61
   PubMed Web of Science ®Google Scholar
• Elion G. B. Enzymatic and metabolic studies with allopurinol. Annals of the Rheumatic Diseases 1966; 25: 608–614
   PubMed Web of Science ®Google Scholar
• Flammang T. J., Kadlubar F. F. Acetyl coenzyme A-dependent metabolic activation of carcinogenic N-hydroxy arylamines. Proceedings of the American Association for Cancer Research 1984; 25: 120–126
   Google Scholar
• Gentle J. E. Least absolute values estimation: an introduction. Communications in Statistics 1977; 3: 313–328
   Google Scholar
• Görnandt L., Kessler M., Vieregge U. PO2 histograms in regenerating liver tissue. Oxygen Supply: Theoretical and Practical Aspects, M. Kessler, D. F. Bruley. Park Press, Baltimore 1973; 271–275
   Google Scholar
• Guest D., Schnell S. R., Rickert D. E., Dent J. G. Metabolism of 2,4-dinitrotoluene by intestinal microorganisms from rat, mouse, and man. Toxicology and Applied Pharmacology 1982; 64: 160–168
   PubMed Web of Science ®Google Scholar
• Hillis L. D., Braunwald E. Myocardial ischemia. New England Journal of Medicine 1977; 296: 971–978
   PubMed Web of Science ®Google Scholar
• Horie A. Advances in research on DT-diaphorase—Catalytic properties, regulation of activity and significance in the detoxication of foreign compounds. Kisato Archives of Experimental Medicine 1990; 63: 11–30
   PubMedGoogle Scholar
• Hunt C. M., Strater S., Stare G. M. Effect of normal aging on the activity of human hepatic cytochrome P-450IIE1. Biochemical Pharmacology 1990; 40: 1666–1669
   PubMed Web of Science ®Google Scholar
• Jonen-Kern R., Jonen H. G., Schupp R. R., Minck K., Fahl G. F., Netter K. J. Reductive drug metabolism in isolated perfused rat liver under restricted oxygen supply. Xenobiotica 1978; 8: 271–280
   PubMed Web of Science ®Google Scholar
• Kedderis G. L., Dyroff M. C., Rickert D. E. Hepatic macromolecular covalent binding of the hepatocarcinogen 2,6-dinitrotoluene and its 2,4-isomer in vivo: modulation by the sulfotrans- ferase inhibitors pentachiorophenol and 2,6-dichloro-4-nitrophenol. Carcinogenesis 1984; 5: 1199–1204
   PubMed Web of Science ®Google Scholar
• King C. M., Glowinski I. B. Acetylation, deacetylation and acyltransfer. Environmental Health Perspectives 1983; 49: 43–50
   PubMed Web of Science ®Google Scholar
• Leonard T. B., Adams T., Popp J. A. Dinitrotoluene isomer-specific enhancement of the expression of diethylnitrosamine initiated hepatocyte foci. Carcinogenesis 1986; 7: 1797–1803
   PubMed Web of Science ®Google Scholar
• Leonard T. B., Graichen M. E., Popp J. A. Dinitrotoluene isomer-specific hepatocarcino-genesis in F344 rats. Journal of the National Cancer Institute 1987; 79: 1313–1319
   PubMed Web of Science ®Google Scholar
• Leonard T. B., Lyght O., Popp J. A. Dinitrotoluene structure-dependent initiation of hepatocytes in vivo. Carcinogenesis 1983; 4: 1059–1061
   PubMed Web of Science ®Google Scholar
• Long R. M., Rickert D. E. Metabolism and excretion of 2,6-dinitrol[14C]toluene in vivo and in isolated perfused rat livers. Drug Metabolism and Disposition 1982; 10: 455–458
   PubMed Web of Science ®Google Scholar
• McLane K. E., Fisher J., Ramakrishnan K. Reductive drug metabolism. Drug Metabolism Reviews 1983; 14: 741–799
   PubMed Web of Science ®Google Scholar
• Mirsalis J. C., Hamm T. E., Jr., Sherrill J. M., Butterworth B. E. Role of gut flora in the genotoxicity of dinitrotoluene. Nature 1982; 295: 322–323
   PubMed Web of Science ®Google Scholar
• Mori M. A., Matsuhashi T., Miyahara T., Shibata S., Izima C., Kozuka H. Reduction of 2,4-dinitrotoluene by Wistar rat liver microsomal and cytosol fractions. Toxicology and Applied Pharmacology 1984; 76: 105–112
   PubMed Web of Science ®Google Scholar
• Neter J., Wasserman W. Applied Linear Statistical Models. Rochard D. Irwin, Inc., Homewood, IL 1974; 77–89; 636–668
   Google Scholar
• Pasto D. J., Johnson C. R. Organic Structure Determination. Prentice-Hall, Inc., Englewood Cliffs, NJ 1969; 327–463
   Google Scholar
• Powis G., Wincentsen L. Pyridine nucleotide cofactor requirements of indicine-N-oxide reduction by hepatic microsomal cytochrome P-450. Biochemical Pharmacology 1980; 29: 347–351
   PubMed Web of Science ®Google Scholar
• Powis G., Jardine I., VanDyke R., Weinshilboum R., Moore D., Wilke T., Rhodes R., Nelson R., Benson L., Szumlauski C. Foreign compounds metabolism: studies with human liver obtained as surgical waste. Relation to donor characteristics and effects of tissue storage. Drug Metabolism and Disposition 1988; 16: 582–589
   PubMed Web of Science ®Google Scholar
• Rajagopalan K. V., Fridovich I., Handler P. Hepatic aldehyde oxidase. I. Purification and properties. Journal of Biological Chemistry 1962; 237: 922–928
   PubMed Web of Science ®Google Scholar
• Remington R. D., Schork M. A. Statistics with Applications to the Biological Health Sciences. Prentice-Hall, Inc., Englewood Cliffs, NJ 1970; 210–213
   Google Scholar
• Rickert D. E., Long R. M., Krakowka S., Dent J. G. Metabolism and excretion of 14C-2,4-dinitrotoluene in conventional and axenic rats. Toxicology and Applied Pharmacology 1981; 59: 574–579
   PubMedGoogle Scholar
• Rickert D. E., Butterworth B. E., Popp J. A. Dinitrotoluene: acute toxicity, oncogenicity, genotoxicity, and metabolism. CRC Critical Reviews in Toxicology 1984; 13: 217–234
   Web of Science ®Google Scholar
• Sato N., Kamada T., Kawano S., Hayashi N., Kishida Y., Meren H., Yoshihara H., Abe H. Effect of acute and chronic ethanol consumption on hepatic tissue oxygen tension in rats. Pharmacology, Biochemistry and Behavior 1983; 18: 443–447
   PubMedGoogle Scholar
• Shoji M., Mori M. A., Kawajiri T., Sayama M., Mori Y., Miyahara T., Honda T., Kozuka H. Metabolism of 2,4-dinitrotoluene, 2,4-dinitrobenzyl alcohol and 2,4-dinitrobenz-aldehyde by rat liver microsomal and cytosol fractions. Chemistry and Pharmaceutical Bulletin 1987; 35: 1579–1586
   PubMed Web of Science ®Google Scholar
• Sugiura M., Iwasaki K., Kato R. Reduced nicotinamide adenine dinucleotide-dependent reduction of tertiary amine N-oxide by liver microsomal cytochrome P-450. Biochemical Pharmacology 1977; 26: 489–495
   PubMed Web of Science ®Google Scholar
• Turner M. J., Jr, Levine R. J., Nystrom D. D., Crume Y. S., Rickert D. E. Identification and quantification of urinary metabolites of dinitrotoluenes in occupationally exposed humans. Toxicology and Applied Pharmacology 1985; 80: 166–174
   PubMed Web of Science ®Google Scholar
• Walton I., Workman P. Nitroimidazole bioreductive metabolism. Quantitation and characterization of mouse tissue benzidazole nitroreductases in vivo and in vitro. Biochemical Pharmacology 1987; 36: 887–896
   PubMedGoogle Scholar
• Woods J. S., Fowler B. A., Eaton D. L. Studies on the mechanisms of thallium-mediated inhibition of hepatic mixed function oxidase activity. Correlation with inhibition of NADPH-cytochrome c (P-450) reductase. Biochemical Pharmacology 1984; 33: 571–576
   PubMedGoogle Scholar
• Woollen B. H., Hall M. G., Craig R., Steel G. T. Dinitrotoluene: an assessment of occupational absorption during the manufacture of blasting explosives. International Archives of Occupational and Environmental Health 1985; 55: 319–330
   PubMed Web of Science ®Google Scholar
• Wynne H., Mutch E., James O. F. W., Wright P., Rawlins M. D., Woodhouse K. W. The effect of age upon the affinity of microsomal monooxygenase enzymes for substrate in human liver. Age and Ageing 1988; 17: 401–405
   PubMed Web of Science ®Google Scholar
• Ziegler D. M. Microsomal flavin-containing monooxygenase: oxygenation of nucleophilic nitrogen and sulfur compounds. Enzymatic Basis of Detoxification, W. B. Jakoby. Academic Press, New York 1980; Vol. 1: 201–227
   Google Scholar